再生医療市場の市場規模、シェア、成長分析、製品別、治療領域別、地域別 - 産業予測 2025-2032年

再生医療の世界市場規模は、2023年に152億米ドルと評価され、2024年の173億7,000万米ドルから2032年には506億1,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは14.3％で成長する見通しです。

再生医療分野は急速に進化しており、身体の自然治癒メカニズムを活用して組織や臓器を修復・再生します。幹細胞、組織工学、成長因子、バイオマテリアルを活用することで、この学際的な分野は、先天性欠損や変性疾患などの症状に対する個別化治療の選択肢など、大きな利点を提示しています。個別化されたヘルスケアソリューションへの需要が高まる中、再生医療は、患者の遺伝的要因やライフスタイルに合わせた治療を行う個別化医療アプローチとシームレスに連携しています。このアプローチは治療効果を高めるだけでなく、臓器移植のような従来の方法への依存を最小限に抑え、患者のQOLを大幅に向上させる。幹細胞技術への投資が増加し、製品の上市数も増加していることから、再生医療市場は近い将来、大きく成長するものと思われます。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 特許分析
• 規制分析
• 技術分析
• ケーススタディ
• 顧客と購買基準の分析

再生医療市場規模：製品別& CAGR（2025-2032）

• 市場概要
• 細胞療法
  • 幹細胞療法
  • 細胞移植
  • 幹細胞治療製品
  • 細胞ベースの免疫療法
• 遺伝子治療
• 組織工学

再生医療市場規模：治療領域別& CAGR（2025-2032）

• 市場概要
• 腫瘍学
• 筋骨格系障害
• 皮膚科・創傷ケア
• 心血管疾患
• 眼科
• 神経学
• その他の治療領域

再生医療市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024年）

主要企業プロファイル

• Novartis AG（Switzerland）
• Biogen, Inc.（USA）
• Sarepta Therapeutics, Inc.（USA）
• Gilead Sciences, Inc.（USA）
• Amgen Inc.（USA）
• Smith+Nephew（UK）
• MEDIPOST Co., Ltd.（Korea）
• JCR Pharmaceuticals Co., Ltd.（Japan）
• Takeda Pharmaceutical Company Limited（Japan）
• CORESTEM, Inc（South Korea）.
• Zimmer Biomet Holdings Inc.（USA）
• AbbVie Inc.（USA）
• Cryolife, Inc（USA）
• Stryker（USA）
• Medtronic Plc（Ireland）

結論と提言

Global Regenerative Medicine Market size was valued at USD 15.2 billion in 2023 and is poised to grow from USD 17.37 billion in 2024 to USD 50.61 billion by 2032, growing at a CAGR of 14.3% during the forecast period (2025-2032).

The regenerative medicine sector is rapidly evolving, leveraging the body's natural healing mechanisms to repair and regenerate tissues and organs. By utilizing stem cells, tissue engineering, growth factors, and biomaterials, this multidisciplinary field presents significant advantages, including personalized treatment options for conditions such as congenital defects and degenerative disorders. As the demand for individualized healthcare solutions rises, regenerative medicine aligns seamlessly with the personalized medicine approach, which tailors treatments to patients' genetic and lifestyle factors. This approach not only enhances treatment efficacy but also minimizes reliance on traditional methods like organ transplantation, thus significantly improving patient quality of life. With increasing investments in stem cell technologies and a growing number of product launches, the regenerative medicine market is poised for substantial growth in the near future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Regenerative Medicine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Regenerative Medicine Market Segments Analysis

Global Regenerative Medicine Market is segmented by Product, Therapeutic Area and region. Based on Product, the market is segmented into Cell Therapy, Gene Therapy and Tissue Engineering. Based on Therapeutic Area, the market is segmented into Oncology, Musculoskeletal Disorders, Dermatology & Wound Care, Cardiovascular Diseases, Ophthalmology, Neurology and Other Therapeutic Areas. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Regenerative Medicine Market

The global regenerative medicine market is being propelled by advancements in precision medicine, a tailored therapeutic approach that considers individual patients' genetic, environmental, and lifestyle factors. This method facilitates the development of customized treatments for rare genetic disorders, including haemophilia B, cerebral adrenoleukodystrophy, beta thalassemia, refractory multiple myeloma, and certain types of non-muscle invasive bladder cancer. As healthcare evolves, the demand for personalized medical solutions that address the unique needs of patients grows, thereby driving innovation and investment in the regenerative medicine sector. This ongoing shift towards precision therapy is expected to significantly elevate the market's growth trajectory in the coming years.

Restraints in the Global Regenerative Medicine Market

The global regenerative medicine market faces significant challenges due to ethical concerns surrounding the use of stem cells derived from human embryos. The destruction of an embryo, which is often considered a potential life, raises moral questions, even when the intention is to save an existing life. These ethical dilemmas regarding the applicability of embryonic stem cells in treatment options contribute to hesitancy and limitations within the market. As these concerns persist, they hinder broader acceptance and advancement of regenerative therapies, ultimately affecting market growth on a global scale. Thus, navigating these ethical landscapes is crucial for the future development of this promising field.

Market Trends of the Global Regenerative Medicine Market

The Global Regenerative Medicine market is witnessing a significant shift driven by advancements in stem cell therapies, which are increasingly recognized for their potential in revolutionizing treatment paradigms. As technologies evolve and clinical applications expand, stem cells are emerging as pivotal in addressing various degenerative diseases and injuries, fostering tissue regeneration and repair. This surge in popularity is bolstered by ongoing research, favorable regulatory environments, and rising investments in the biotech sector. With a growing demand for personalized medicine and innovative therapies, the regenerative medicine market is expected to continue its rapid growth trajectory, promising enhanced patient outcomes and transforming healthcare options worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Patent Analysis
• Regulatory Analysis
• Technology Analysis
• Case Studies
• Customer And Buying Criteria Analysis

Global Regenerative Medicine Market Size by Product & CAGR (2025-2032)

• Market Overview
• Cell Therapy
  • Stem Cell Therapy
  • Cell transplantations
  • Stem cell therapy products
  • Cell-Based Immunotherapy
• Gene Therapy
• Tissue Engineering

Global Regenerative Medicine Market Size by Therapeutic Area & CAGR (2025-2032)

• Market Overview
• Oncology
• Musculoskeletal Disorders
• Dermatology & Wound Care
• Cardiovascular Diseases
• Ophthalmology
• Neurology
• Other Therapeutic Areas

Global Regenerative Medicine Market Size & CAGR (2025-2032)

• North America (Product, Therapeutic Area)
  • US
  • Canada
• Europe (Product, Therapeutic Area)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Therapeutic Area)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Therapeutic Area)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Therapeutic Area)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogen, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sarepta Therapeutics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith+Nephew (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MEDIPOST Co., Ltd. (Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JCR Pharmaceuticals Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CORESTEM, Inc (South Korea).
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet Holdings Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cryolife, Inc (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations